Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation · 2019
Severe Respiratory Syncytial Virus Pneumonia in a Kidney Transplant Recipient With Desensitization: Case Report and Comprehensive Review of the Literature.
Клинический случайСтатьяПоддержка исследования: вне правительства СШАОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Lee Eun Song, Kim Kyu Yeun, Jeong Kye-Hwa, Lim Jeong-Hoon, Jung Hee-Yeon, Choi Ji-Young, Cho Jang-Hee, Park Sun-Hee, Kim Yong-Lim, Kim Chan-Duck
Аннотация
Herein, we report a rare case of severe respiratory syncytial virus pneumonia after kidney transplant in a 46-year-old woman. The patient was diagnosed with end-stage renal disease and underwent living-donor kidney transplant. Direct flow cytometry crossmatch testing yielded positive results, and desensitization treatment with rituximab, plasmapheresis, and im-munoglobulin was performed before transplant. There were no complications. Five days after discharge, the patient was readmitted with a 2-day history of fever and diagnosed with bilateral pneumonia. The patient was placed on mechanical ventilation and given renal replacement therapy. Respiratory syncytial virus in the bronchial washings was detected via polymerase chain reaction. Broad-spectrum antibiotics, intravenous methylprednisolone, and immunoglobulin were admin-istered. Over-immunosuppression strategies, such as desensitization therapy, may result in severe respiratory syncytial virus pneumonia, even in kidney transplant recipients.
Предметные рубрики MeSH
Desensitization, ImmunologicFemaleHumansImmunocompromised HostImmunoglobulins, IntravenousImmunosuppressive AgentsKidney Failure, ChronicKidney TransplantationLiving DonorsMiddle AgedOpportunistic InfectionsPlasmapheresisPneumonia, ViralRespiratory Syncytial Virus InfectionsRespiratory Syncytial Virus, HumanRituximabSeverity of Illness IndexTreatment Outcome